Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196


An Msh2 point mutation uncouples DNA mismatch repair and apoptosis.

Lin DP, Wang Y, Scherer SJ, Clark AB, Yang K, Avdievich E, Jin B, Werling U, Parris T, Kurihara N, Umar A, Kucherlapati R, Lipkin M, Kunkel TA, Edelmann W.

Cancer Res. 2004 Jan 15;64(2):517-22.


Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.

Reitmair AH, Risley R, Bristow RG, Wilson T, Ganesh A, Jang A, Peacock J, Benchimol S, Hill RP, Mak TW, Fishel R, Meuth M.

Cancer Res. 1997 Sep 1;57(17):3765-71.


[The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].

Czakó L, Tiszlavicz L, Takács R, Baradnay G, Lonovics J, Cserni G, Závodná K, Bartosova Z.

Orv Hetil. 2005 May 15;146(20):1009-16. Hungarian.


Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation.

DeWeese TL, Shipman JM, Larrier NA, Buckley NM, Kidd LR, Groopman JD, Cutler RG, te Riele H, Nelson WG.

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11915-20.


1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.

Colussi C, Fiumicino S, Giuliani A, Rosini S, Musiani P, Macrí C, Potten CS, Crescenzi M, Bignami M.

J Natl Cancer Inst. 2001 Oct 17;93(20):1534-40.


Msh-2 suppresses in vivo mutation in a gene dose and lesion dependent manner.

Sansom OJ, Toft NJ, Winton DJ, Clarke AR.

Oncogene. 2001 Jun 14;20(27):3580-4.


Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine.

Toft NJ, Winton DJ, Kelly J, Howard LA, Dekker M, te Riele H, Arends MJ, Wyllie AH, Margison GP, Clarke AR.

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3911-5.


Functional analysis of HNPCC-related missense mutations in MSH2.

Lützen A, de Wind N, Georgijevic D, Nielsen FC, Rasmussen LJ.

Mutat Res. 2008 Oct 14;645(1-2):44-55. doi: 10.1016/j.mrfmmm.2008.08.015. Epub 2008 Sep 4.


Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts.

Andrew SE, Xu XS, Baross-Francis A, Narayanan L, Milhausen K, Liskay RM, Jirik FR, Glazer PM.

Carcinogenesis. 2000 Jul;21(7):1291-5.


MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.

Reitmair AH, Cai JC, Bjerknes M, Redston M, Cheng H, Pind MT, Hay K, Mitri A, Bapat BV, Mak TW, Gallinger S.

Cancer Res. 1996 Jul 1;56(13):2922-6.


Mammalian DNA mismatch repair protects cells from UVB-induced DNA damage by facilitating apoptosis and p53 activation.

Peters AC, Young LC, Maeda T, Tron VA, Andrew SE.

DNA Repair (Amst). 2003 Apr 2;2(4):427-35.


Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.

Humbert O, Fiumicino S, Aquilina G, Branch P, Oda S, Zijno A, Karran P, Bignami M.

Carcinogenesis. 1999 Feb;20(2):205-14.


Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair.

Pichierri P, Franchitto A, Piergentili R, Colussi C, Palitti F.

Carcinogenesis. 2001 Nov;22(11):1781-7.


Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis.

Russo MT, De Luca G, Casorelli I, Degan P, Molatore S, Barone F, Mazzei F, Pannellini T, Musiani P, Bignami M.

Cancer Res. 2009 May 15;69(10):4372-9. doi: 10.1158/0008-5472.CAN-08-3292. Epub 2009 May 12.


Mouse mismatch repair gene Msh2 is not essential for transcription-coupled repair of UV-induced cyclobutane pyrimidine dimers.

Sonneveld E, Vrieling H, Mullenders LH, van Hoffen A.

Oncogene. 2001 Jan 25;20(4):538-41.


Distinct effects of the recurrent Mlh1G67R mutation on MMR functions, cancer, and meiosis.

Avdievich E, Reiss C, Scherer SJ, Zhang Y, Maier SM, Jin B, Hou H Jr, Rosenwald A, Riedmiller H, Kucherlapati R, Cohen PE, Edelmann W, Kneitz B.

Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4247-52. doi: 10.1073/pnas.0800276105. Epub 2008 Mar 12.

Items per page

Supplemental Content

Write to the Help Desk